Cargando…
Choosing the safest acute combination therapy during prophylactic treatment: pharmacokinetic and pharmacodynamic considerations
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Milan
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759361/ https://www.ncbi.nlm.nih.gov/pubmed/28132352 http://dx.doi.org/10.1186/1129-2377-16-S1-A36 |
| _version_ | 1782416713844785152 |
|---|---|
| author | Lionetto, Luana Martelletti, Paolo |
| author_facet | Lionetto, Luana Martelletti, Paolo |
| author_sort | Lionetto, Luana |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4759361 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Springer Milan |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47593612016-03-01 Choosing the safest acute combination therapy during prophylactic treatment: pharmacokinetic and pharmacodynamic considerations Lionetto, Luana Martelletti, Paolo J Headache Pain Invited Speaker Presentation Springer Milan 2015-09-28 /pmc/articles/PMC4759361/ /pubmed/28132352 http://dx.doi.org/10.1186/1129-2377-16-S1-A36 Text en © Lionetto and Martelletti 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Invited Speaker Presentation Lionetto, Luana Martelletti, Paolo Choosing the safest acute combination therapy during prophylactic treatment: pharmacokinetic and pharmacodynamic considerations |
| title | Choosing the safest acute combination therapy during prophylactic treatment: pharmacokinetic and pharmacodynamic considerations |
| title_full | Choosing the safest acute combination therapy during prophylactic treatment: pharmacokinetic and pharmacodynamic considerations |
| title_fullStr | Choosing the safest acute combination therapy during prophylactic treatment: pharmacokinetic and pharmacodynamic considerations |
| title_full_unstemmed | Choosing the safest acute combination therapy during prophylactic treatment: pharmacokinetic and pharmacodynamic considerations |
| title_short | Choosing the safest acute combination therapy during prophylactic treatment: pharmacokinetic and pharmacodynamic considerations |
| title_sort | choosing the safest acute combination therapy during prophylactic treatment: pharmacokinetic and pharmacodynamic considerations |
| topic | Invited Speaker Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759361/ https://www.ncbi.nlm.nih.gov/pubmed/28132352 http://dx.doi.org/10.1186/1129-2377-16-S1-A36 |
| work_keys_str_mv | AT lionettoluana choosingthesafestacutecombinationtherapyduringprophylactictreatmentpharmacokineticandpharmacodynamicconsiderations AT martellettipaolo choosingthesafestacutecombinationtherapyduringprophylactictreatmentpharmacokineticandpharmacodynamicconsiderations |